Last reviewed · How we verify
NCT03700632
Part-time Patch Therapy for Treatment of Intermittent Exotropia
NA trial testing patch therapy in Intermittent Exotropia in 64 participants. Status unknown.
10 May 2020
Quick facts
| Lead sponsor | Tehran University of Medical Sciences |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 1 November 2018 |
| Primary completion | 10 May 2020 |
| Estimated completion | 10 November 2021 |
Drugs / interventions tested
- patch therapy
Conditions studied
- Intermittent Exotropia — all drugs for Intermittent Exotropia →
Sponsor
Tehran University of Medical Sciences
Who can join
Adults 3 to 8, any sex, with Intermittent Exotropia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Intermittent exotropia is the most common type of exotropia in children. Treatment options are surgical and non surgical. Nonsurgical management include Correction of refractive errors, Active orthoptic treatments, Prisms and Occlusion therapy. Benefits of patch therapy are limiting suppression, reducing the frequency and amplitude of the deviation, changing the nature of the deviation (from constant to intermittent exotropia or from intermittent exotropia to exophoria), however, there is a concern that occlusion of the eyes may cause fusion failure and worsen deviation control. According to a few number of studies and controversy among the results of investigations, the investigators designed this randomized clinical trial study to determine the effect of partial patch therapy on the deviation control of children with intermittent exotropia.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The influence of alternate part-time patching on control of intermittent exotropia: a randomized clinical trial.
Akbari MR, Mehrpour M, Mirmohammadsadeghi A. · · 2021 · cited 10× · PMID 33415357 · DOI 10.1007/s00417-020-05065-0
Verify or expand the search:
- PubMed search for NCT03700632
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Tehran University of Medical Sciences trials
Trials by the same sponsor.
- NCT07305883 — Comparison of Intranasal Ketorolac and Intranasal Ketamine in Digital Nerve Block Pain · Phase 3 · not yet recruiting
- NCT06876194 — The Effect of Music on the Sedation Quality Among Children in the Emergency Department. · Phase 3 · completed
- NCT06721273 — Iodine Supplementation and Fertility Parameters · NA · not yet recruiting
- NCT07014397 — Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic Teeth · NA · completed
- NCT06615934 — Effects of Aerobic and Resistance Exercises on Inpatients Liver Transplantation Recipients · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03700632 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tehran University of Medical Sciences
- Last refreshed: 9 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03700632.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing